Cargando…
Negative influence of programmed death‐1‐ligands on the survival of esophageal cancer patients treated with chemotherapy
The programmed death‐1/programmed death‐1 ligands (PD‐1/PD‐L) pathway plays an important role in immunological tumor evasion. However, the clinical significance of the PD‐L (L1 and L2) expression in esophageal cancer treated with chemotherapy has not been fully investigated. We examined the expressi...
Autores principales: | Tanaka, Koji, Miyata, Hiroshi, Sugimura, Keijiro, Kanemura, Takashi, Hamada‐Uematsu, Mika, Mizote, Yu, Yamasaki, Makoto, Wada, Hisashi, Nakajima, Kiyokazu, Takiguchi, Shuji, Mori, Masaki, Doki, Yuichiro, Tahara, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968603/ https://www.ncbi.nlm.nih.gov/pubmed/27015293 http://dx.doi.org/10.1111/cas.12938 |
Ejemplares similares
-
Immunoregulatory influence of abundant MFG‐E8 expression by esophageal cancer treated with chemotherapy
por: Kanemura, Takashi, et al.
Publicado: (2018) -
Assessment of stanniocalcin-1 as a prognostic marker in human esophageal squamous cell carcinoma
por: SHIRAKAWA, MITSUHIRO, et al.
Publicado: (2011) -
Expression of insulin-like growth factor-II mRNA-binding protein-3 as a marker for predicting clinical outcome in patients with esophageal squamous cell carcinoma
por: TAKATA, AKIHIRO, et al.
Publicado: (2014) -
PRIMA‐1 induces p53‐mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation
por: Furukawa, Haruna, et al.
Publicado: (2017) -
Poly (ADP-ribose) polymerase-1 inhibition decreases proliferation through G2/M arrest in esophageal squamous cell carcinoma
por: Yamamoto, Masaaki, et al.
Publicado: (2017)